hAd5-Covid-19
- Generic Name
- hAd5-Covid-19
COVID-19 Subcutaneously and Orally Administered Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines
- First Posted Date
- 2021-04-14
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- ImmunityBio, Inc.
- Registration Number
- NCT04845191
COVID-19 Supplemental Vaccine Boost to Enhance T Cell Protection in Those Who Have Already Received EUA S-Based Vaccines
- First Posted Date
- 2021-04-13
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- ImmunityBio, Inc.
- Registration Number
- NCT04843722
COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults
- First Posted Date
- 2021-01-14
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- ImmunityBio, Inc.
- Target Recruit Count
- 41
- Registration Number
- NCT04710303
- Locations
- πΏπ¦
Khayelitsha Clinical Research Site, Khayelitsha, South Africa
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
Β© Copyright 2025. All Rights Reserved by MedPath